1. Home
  2. MYNZ vs ADXN Comparison

MYNZ vs ADXN Comparison

Compare MYNZ & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYNZ
  • ADXN
  • Stock Information
  • Founded
  • MYNZ 2021
  • ADXN 2002
  • Country
  • MYNZ Germany
  • ADXN Switzerland
  • Employees
  • MYNZ N/A
  • ADXN N/A
  • Industry
  • MYNZ Biotechnology: Pharmaceutical Preparations
  • ADXN Biotechnology: Pharmaceutical Preparations
  • Sector
  • MYNZ Health Care
  • ADXN Health Care
  • Exchange
  • MYNZ Nasdaq
  • ADXN Nasdaq
  • Market Cap
  • MYNZ 9.8M
  • ADXN 8.9M
  • IPO Year
  • MYNZ 2021
  • ADXN N/A
  • Fundamental
  • Price
  • MYNZ $0.38
  • ADXN $8.01
  • Analyst Decision
  • MYNZ Buy
  • ADXN
  • Analyst Count
  • MYNZ 2
  • ADXN 0
  • Target Price
  • MYNZ $3.00
  • ADXN N/A
  • AVG Volume (30 Days)
  • MYNZ 1.4M
  • ADXN 2.1K
  • Earning Date
  • MYNZ 08-13-2024
  • ADXN 08-08-2024
  • Dividend Yield
  • MYNZ N/A
  • ADXN N/A
  • EPS Growth
  • MYNZ N/A
  • ADXN N/A
  • EPS
  • MYNZ N/A
  • ADXN N/A
  • Revenue
  • MYNZ $895,479.00
  • ADXN $1,568,105.00
  • Revenue This Year
  • MYNZ $67.40
  • ADXN N/A
  • Revenue Next Year
  • MYNZ $191.13
  • ADXN N/A
  • P/E Ratio
  • MYNZ N/A
  • ADXN N/A
  • Revenue Growth
  • MYNZ 69.00
  • ADXN N/A
  • 52 Week Low
  • MYNZ $0.32
  • ADXN $5.00
  • 52 Week High
  • MYNZ $4.79
  • ADXN $27.90
  • Technical
  • Relative Strength Index (RSI)
  • MYNZ 39.67
  • ADXN 41.23
  • Support Level
  • MYNZ $0.39
  • ADXN $8.01
  • Resistance Level
  • MYNZ $0.46
  • ADXN $8.40
  • Average True Range (ATR)
  • MYNZ 0.08
  • ADXN 0.19
  • MACD
  • MYNZ 0.01
  • ADXN 0.07
  • Stochastic Oscillator
  • MYNZ 26.53
  • ADXN 20.96

About MYNZ Mainz Biomed N.V.

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.

Share on Social Networks: